Additionally, we observed micro- and macrovesicular lipid inclusions within the hepatocytes of HFI, with elevated steatosis volume, plasma TAG and cholesterol concentrations, and decreased expression of beta-oxidation-related genes (Ppargama, Pgc1a, and Cpt1a). The gene discussed is PPARGC1A; the disease is steatosis.